✦ LIBER ✦

Economic analysis of adjuvant therapy with interferon alpha-2a in stage II malignant melanoma

✍ Scribed by A. Lafuma; B. Dreno; M. Delaunay; C. Emery; F. Fagnani; K. Hieke; J.-J. Bonerandi; J.-J. Grob

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of STAT1 and STAT2 in maligna

✍ Gregory B. Lesinski; Daniel Valentino; Erinn M. Hade; Susie Jones; Cynthia Magro 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 715 KB

Cost–Utility of Adjuvant High-Dose Inter

✍ R. Crott; F. Ali; S. Burdette-Radoux 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Mediastinal sarcoidosis induced by high-

✍ Sara Massaguer; Marcelo Sánchez; Teresa Castel 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 143 KB

Adjuvant treatment with interferon-α in

✍ Ascierto, P.A.; Daponte, A.; Parasole, R.; Palmieri, G.; Mozzillo, N.; Castello, 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Effect of long-term adjuvant therapy wit

✍ Natale Cascinelli; Filiberto Belli; Rona M MacKie; Mario Santinami; Rosaria Bufa 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 80 KB

213 Interferon α 2 A as an adjuvant ther

✍ Grob; Dreno; Delaunay; Cupissol; Guillot; Souteyrand; Guillet; Cesarini; Thivole 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 156 KB